# Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prostate-specific-antigen-at-4-to-5-years-after-low-dose-rate-prostate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrea Lo,William Morris,Vincent Lapointe,Jeremy Hamm,Mira Keyes,Tom Pickles,Michael McKenzie,Ingrid Spadinger |
| Citations | 58 |
| DOI | 10.1016/j.ijrobp.2013.10.010 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1965536955 |
| PMID | 24331654 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jeremy Hamm](https://scholariq.org/researchers/jeremy-hamm/)

## Paper journal

- [International Journal of Radiation Oncology*Biology*Physics](https://scholariq.org/journals/international-journal-of-radiation-oncology-biology-physics/)

## Paper primary topic

- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Paper topics

- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.